Federal Judge Approves Generic Drug Settlement With Only Injunctive Relief

Federal Judge Approves Generic Drug Settlement With Only Injunctive Relief

PHILADELPHIA - The Pennsylvania federal judge supervising consumer fraud litigation against the manufacturer and distributor of a generic version of the antidepressant Wellbutrin XL approved a settlement on July 2 that incorporates only injunctive relief and awarded $3.2 million in attorney fees (In re: Budeprion XL Marketing and Sales Practices Litigation, MDL 2107, No. 2:09-md-2107, E.D. Pa.; 2012 U.S. Dist. LEXIS 91176).

Find full version on lexis Advance®
Access this news story on lexis.com®